TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.

Nai-Kong V Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.